NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,316 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,316 Papers indexed
1,440 Papers AI scored
40,316 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-11 10:15 AM
1 Sensitive LC-MS/MS Method for Simultaneous Quantification of Alectinib and Its Major Metabolite M4 in Limited-Volume Human Plasma. Biomedical chromatography : BMC — Nov 11, 2026 2 Patient reimbursement in therapeutic cancer clinical trials: An 18-year multicenter experience. Cancer — Nov 11, 2026 3 Adulthood risk of non-communicable diseases associated with childhood and adolescent malnutrition in low- and middle-income countries: a systematic review of observational studies. BMJ global health — Nov 11, 2026 4 Parental night shift work and risk of breast cancer in daughters. Environmental research — Nov 11, 2026 5 Influence of diaphragm structure and function on the exercise ventilatory response in childhood cancer survivors and non-cancer controls. Respiratory medicine — Nov 11, 2026 6 Pregnancy and classic Hodgkin lymphoma: real world outcomes from a single center in Egypt. Current problems in cancer — Nov 11, 2026 7 Racial and Ethnic Differences in the Incidence of Langerhans Cell Histiocytosis Across the Age Spectrum. Blood advances — Nov 11, 2026 8 International Cross-Age Consensus Guideline on Measurable Residual Disease Assessment in Acute Lymphoblastic Leukemia. Blood — Nov 11, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40316 results
D
Isolated Ocular Relapse of Pediatric Acute Lymphoblastic Leukemia.
PMID 41728169 Published: 2025-05-18 Ingested: 2026-08-01 11:55 PM Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Flow cytometric analysis of cerebrospinal fluid identifies patients with occult central nervous system involvement in relapsed pediatric acute lymphoblastic leukemia.
PMID 40637739 Published: 2025-07-10 Ingested: 2026-08-02 12:04 AM Haematologica
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Pharmacokinetics of melphalan and adverse events in pediatric AML patients receiving a uniform conditioning regimen.
PMID 40607683 Published: 2025-01-01 Ingested: 2026-08-02 12:03 AM Pediatrics international : official journal of the Japan Pediatric Society
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Extramedullary Relapse of CBFA2T3::GLIS2-Positive Megakaryoblastic Leukemia Mimicking Secondary Ewing Sarcoma: An Exemplary Case for the Diagnostic Trap.
PMID 40565358 Published: 2025-06-19 Ingested: 2026-08-02 12:04 AM International journal of molecular sciences
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

D
Correction to: Neighborhood-level social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival.
PMID 40540432 Published: 2025-04-30 Ingested: 2026-08-02 12:04 AM JNCI cancer spectrum
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Lower-dose venetoclax (LoVe) based regimes in children with acute leukemia.
PMID 40530887 Published: 2025-06-18 Ingested: 2026-08-02 12:04 AM Leukemia & lymphoma
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Response Letter to Ameya et al. Correspondence to the Editor: Reirradiation in Paediatric Tumours of the Central Nervous System: Outcome and Side Effects after Implementing National Guidelines.
PMID 39951885 Published: 2025-01-30 Ingested: 2026-08-02 12:03 AM Clinical oncology (Royal College of Radiologists (Great Britain))
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Does obesity affect children's likelihood of survival after being diagnosed with cancer?
PMID 39933770 Published: 2025-02-01 Ingested: 2026-08-02 12:03 AM Saudi medical journal
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study.
PMID 39605204 Published: 2024-11-28 Ingested: 2026-08-02 12:02 AM Haematologica
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

D
Blood Cancers Reported in Seven Children Dosed with SKYSONA™.
PMID 39535742 Published: 2024-10-31 Ingested: 2026-08-02 12:02 AM Human gene therapy
AI -
Standard 48.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 48.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

Previous
Page 3007 of 3360
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic